DANVERS, MA -- Cell Signaling Technology, Inc. announced that it had signed an agreement with Bristol-Myers Squibb to perform a phosphoproteomic research for the drug giant.
While terms of the agreement were not disclosed, the company indicated that the research to be done included its PhosphoScan technology to provide Bristol-Myers with cellular phospho-profiles of a small molecule kinase inhibitor.
Cell Signaling Technology has a large product line of phospho-related testing systems and supplies.